These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 34533783)
1. Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand. Krittayaphong R; Permsuwan U Clin Drug Investig; 2021 Oct; 41(10):907-915. PubMed ID: 34533783 [TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand. Krittayaphong R; Permsuwan U Am J Cardiovasc Drugs; 2018 Oct; 18(5):405-413. PubMed ID: 29926351 [TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction. King JB; Shah RU; Bress AP; Nelson RE; Bellows BK JACC Heart Fail; 2016 May; 4(5):392-402. PubMed ID: 27039128 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. Gaziano TA; Fonarow GC; Claggett B; Chan WW; Deschaseaux-Voinet C; Turner SJ; Rouleau JL; Zile MR; McMurray JJ; Solomon SD JAMA Cardiol; 2016 Sep; 1(6):666-72. PubMed ID: 27438344 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Ademi Z; Pfeil AM; Hancock E; Trueman D; Haroun RH; Deschaseaux C; Schwenkglenks M Swiss Med Wkly; 2017; 147():w14533. PubMed ID: 29185253 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction. Liang L; Bin-Chia Wu D; Aziz MIA; Wong R; Sim D; Leong KTG; Wei YQ; Tan D; Ng K J Med Econ; 2018 Feb; 21(2):174-181. PubMed ID: 28959905 [TBL] [Abstract][Full Text] [Related]
7. Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea. Park SK; Hong SH; Kim H; Kim S; Lee EK Clin Ther; 2019 Jun; 41(6):1066-1079. PubMed ID: 31101372 [TBL] [Abstract][Full Text] [Related]
8. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. DeVore AD; Braunwald E; Morrow DA; Duffy CI; Ambrosy AP; Chakraborty H; McCague K; Rocha R; Velazquez EJ; JAMA Cardiol; 2020 Feb; 5(2):202-207. PubMed ID: 31825471 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. Gaziano TA; Fonarow GC; Velazquez EJ; Morrow DA; Braunwald E; Solomon SD JAMA Cardiol; 2020 Nov; 5(11):1236-1244. PubMed ID: 32785628 [TBL] [Abstract][Full Text] [Related]
11. Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis. Perera K; Ademi Z; Liew D; Zomer E Eur J Prev Cardiol; 2021 Aug; 28(9):966-972. PubMed ID: 34402869 [TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction. Sandhu AT; Ollendorf DA; Chapman RH; Pearson SD; Heidenreich PA Ann Intern Med; 2016 Nov; 165(10):681-689. PubMed ID: 27571284 [TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective. Chin KL; Zomer E; Wang BH; Liew D Heart Lung Circ; 2020 Sep; 29(9):1310-1317. PubMed ID: 32303468 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analyses of sacubitril-valsartan for heart failure. Liu XQ; He LS; Huang JQ; Xiong LJ; Xia C; Lao HY Heart Fail Rev; 2021 Sep; 26(5):1119-1130. PubMed ID: 32405811 [TBL] [Abstract][Full Text] [Related]
15. An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands. van der Pol S; Degener F; Postma MJ; Vemer P Value Health; 2017 Mar; 20(3):388-396. PubMed ID: 28292483 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Berg DD; Samsky MD; Velazquez EJ; Duffy CI; Gurmu Y; Braunwald E; Morrow DA; DeVore AD Circ Heart Fail; 2021 Feb; 14(2):e007034. PubMed ID: 33530704 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States. Zueger PM; Kumar VM; Harrington RL; Rigoni GC; Atwood A; DiDomenico RJ; Touchette DR Pharmacotherapy; 2018 May; 38(5):520-530. PubMed ID: 29601093 [TBL] [Abstract][Full Text] [Related]
18. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Velazquez EJ; Morrow DA; DeVore AD; Ambrosy AP; Duffy CI; McCague K; Hernandez AF; Rocha RA; Braunwald E Am Heart J; 2018 Apr; 198():145-151. PubMed ID: 29653636 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Morrow DA; Velazquez EJ; DeVore AD; Prescott MF; Duffy CI; Gurmu Y; McCague K; Rocha R; Braunwald E Eur Heart J; 2019 Oct; 40(40):3345-3352. PubMed ID: 31093657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]